Key Highlights
- Revenue rose 8.8% to USD 99.3 million in the third quarter from USD 91.2 million, with products up USD 5.9 million to USD 58.2 million and services up USD 2.2 million to USD 41.1 million.
- Net loss attributable to the company widened to USD 33.5 million, or USD 0.21 per share, from USD 18.1 million, or USD 0.14, as a USD 12.5 million litigation accrual hit SG&A.
- Gross profit margin improved to 35.0% from 32.3%, while Research and Development expense dropped 37.2% to USD 10.1 million after restructuring and divestitures.
- Cash and cash equivalents were USD 91.3 million at September 30, 2026, with USD 27.1 million of short-term investments and USD 92.0 million of 2030 notes outstanding.
Revenue Growth Led by Dental and Parts Manufacturing
3D Systems (NYSE:DDD) filed its Quarterly Report on November 4, 2026 for the three months ended September 30, 2026. The company sells 3D printers, materials, software and services across two segments, Healthcare Solutions and Industrial Solutions. Revenue of USD 99.3 million rose USD 8.1 million, or 8.8%, driven by higher printer and dental materials Volume and parts Manufacturing services. Healthcare Solutions revenue grew 14.4% to USD 49.0 million, helped by dental volume including a key customer, while Industrial Solutions rose 3.9% to USD 50.3 million. For nine months, revenue was USD 289.4 million, up 3.1% from USD 280.6 million, as divestitures weighed on the industrial segment.
A USD 12.5 Million Intrepid Verdict Drives the Wider Loss
Loss from operations widened to USD 24.5 million from USD 21.3 million. The company received an unfavorable Jury verdict in litigation involving Intrepid Automation and booked a USD 12.5 million accrual in selling, general and administrative expense, which rose 33.5% to USD 46.4 million. It plans to seek post-trial relief and may need to restrict cash as Collateral for a bond. A USD 2.9 million asset Impairment and a USD 6.3 million foreign exchange loss added pressure, so net loss reached USD 33.5 million. Gross profit rose USD 5.4 million, or 18.2%, to USD 34.8 million on higher volume. Research and development fell USD 6.0 million on restructuring and cost actions.
Liquidity, Convertible Notes and Covenant Watch
Cash and cash equivalents fell USD 4.3 million from year end to USD 91.3 million, after USD 17.5 million of operating cash use and USD 8.3 million of capital expenditures, partly offset by USD 53.8 million of gross proceeds from an Equity raise in the first nine months. 3D Systems (NYSE:DDD) must hold at least USD 20.0 million of qualified cash under its 2030 notes indenture and said it was in compliance. The 5.875% 2030 notes have USD 92.0 million outstanding, and a small USD 3.9 million balance of 0% notes matures on November 15, 2026. Risks include the verdict outcome, concentration in a few customers and uneven printer sales cycles.
Where Things Stand
The verdict cost the company a USD 12.5 million accrual, which is more than the entire USD 11.6 million rise in SG&A and a large part of the wider net loss. 3D Systems (NYSE:DDD) otherwise showed improvement, with 8.8% revenue growth, a gross margin of 35.0% and a sharply lower R&D bill. Watch post-trial motions in the Intrepid matter, any cash collateral requirement, repayment of the 2026 notes in November and whether dental and parts manufacturing growth carries into the next quarters.






Please wait processing your request...